Due to recent changes in the official account push mechanism, we welcome you to set Boom Health as a "starred" account on the homepage of the official account to get the latest trends and expert insights in the digital healthcare industry第一时间!
01 Global Digital Health Investment and Financing OverviewNalu Medical, a Provider of Long-Term Pain Solutions, Completes $85 Million Series E FinancingOn March 6, Nalu Medical, a provider of long-term pain solutions, completed an $85 million Series E financing round led by B Capital. Nalu offers a miniature implantable pulse generator (iPG) to alleviate chronic pain in patients. The company plans to use the funds to accelerate commercial growth, expand clinical and health economic evidence, and continue product development and operational scaling.Dental Care Service Provider Overjet Secures $53.2 Million in Series C FundingOn March 5, dental care service provider Overjet secured $53.2 million in Series C funding, led by March Capital. Overjet uses artificial intelligence to analyze dental data to determine the treatments patients need, enabling them to receive better dental care. The company plans to use the funds to expand its AI platform and create the first unified standard for dental providers and payers.AI Healthcare Navigation Platform Healthee Raises $32 Million in Series A FundingOn March 4, AI healthcare navigation platform Healthee raised $32 millionSeries A Financing, this round was jointly led by Fin Capital, Glilot Capital Partners, and Group11. Healthee simplifies healthcare navigation through an AI-driven application, providing fast and accurate guidance. The company plans to use the funds to expand its business scale, accelerate product development, and support expansion initiatives.Generic Drug Omnichannel Retail Platform Zeno Health Raises $25 Million in Series C FundingOn March 4, Zeno Health, a generic drug omnichannel retail platform, secured $25 million in Series C funding. This round was led by STIC Investments, with participation from existing investor Lightbox. Founded in 2017, Zeno Health is a pharmacy focused on generic drugs, operating more than 175 stores in Mumbai and Pune. The company plans to use the funds to expand its operations and business scope, as well as to increase development efforts.Healthcare IT Platform Provider Moxe Health Secures $25 Million in FinancingOn February 29, Moxe Health, a provider of medical information technology platforms, secured $25 million in financing from Trinity Capital. The company offers tools for payers and providers to share patient health information and will use the funds to expand its business scale.Online Mental Health Diagnosis and Treatment Platform Tava Health Secures $20 Million in Series B FundingOn March 6, Tava Health, an online mental health diagnosis and treatment platform, secured $20 million in Series B funding, led by Catalyst Investors. The new funds will be used for extensive product development, expanding Tava Health's supplier network, and strengthening collaborations with employers and health insurance companies. As part of the investment, Kapil Desai, a partner at Catalyst Investors, will join the company’s board of directors.CDMO Service Provider Sino-Biocan Completes Nearly RMB 100 Million Series B FinancingOn March 4, Sino-Biocan, a CDMO service provider, completed a nearly RMB 100 million Series B financing round. This round was led by Daotong Investment, with participation from Qikun Fund and Jinjue Investment. Existing shareholders Gaoke Xinjun, Yuanyi Investment, and Innovation Works continued to increase their investment, while Yuanshi Investment and others served as financial advisors for this round. The funds raised will mainly be used for building a modern production system, comprehensively enhancing R&D capabilities, and global registration certificate capacity, as well as rapidly expanding into key global markets.BrainCheck, a Digital Brain Health Testing Platform, Raises $15 Million in FinancingOn March 6, BrainCheck, a digital brain health testing platform, secured $15 million in funding. This round was led by Next Coast Ventures, S3 Ventures, and UPMC Enterprises. The funding will accelerate BrainCheck's commercialization process, expand the scope of innovation in its product portfolio, consolidate existing clinical evidence, and enhance the company’s influence across the entire healthcare sector, including significant integration with healthcare systems.Clinical Psychology AI Technology Provider Limbic Secures $14 Million in FundingOn March 5, Limbic, a provider of clinical psychology AI technology, secured $14 million in funding. This round was led by Khosla Ventures, with participation from Gaingels and Illusian. The newly acquired funds will be used to expand the availability of Limbic's artificial intelligence solutions to healthcare providers in the United States. Initial partnerships with U.S. healthcare systems and payers will be announced in the coming months.Home Healthcare Platform Kismet Raises $8.2 Million in Seed FundingOn March 4, Kismet, a home care platform, secured $8.2 million in seed funding led by Prosus Ventures and Airtree Ventures. Kismet, through its integrated digital ecosystem catering to the global home-based, disabled, and elderly populations, is committed to expanding and enhancing care services. The company plans to use the funds to reinforce its commitment to global health engagement and strengthen its team and worldwide operations.Cardiac Solutions Provider Chamber Cardio Secures $8 Million in FinancingOn March 6, Chamber Cardio, a cardiac solutions provider, raised $8 million in funding. This round was led by General Catalyst, with support from existing investor AlleyCorp, and participation from Company Ventures, American Family Ventures, and City Light. The company plans to use the funds to further develop its technology, expand its cardiology network across China, and grow its team.Digital Gastrointestinal Care Company Salvo Health Secures $5 Million in Seed FundingOn February 29, Salvo Health, a digital gastrointestinal care company, raised $5 million in seed funding led by City Light Capital and Human Ventures, with participation from the company’s existing investors. The company provides a virtual care clinic for people with chronic gastrointestinal conditions and will use the funds to expand its network of provider connections.Digital Musculoskeletal Health Platform Vitrue Health Raises $4 Million in FundingOn February 29, Vitrue Health, a digital musculoskeletal health platform provider, secured $4 million in funding led by MC Ventures and Hambro Perks, with participation from Simplyhealth Ventures, Crista Galli Ventures, and Chris Bruce. The total funding has now reached $7 million. The company plans to use the proceeds to further expand its team and drive its expansion into new markets in the U.S. and Europe.Digital Therapeutics Developer for Mental Rehabilitation, Shanghai Qianqiu Intelligent Technology Co., Ltd., Secures Multi-Million Angel Round FinancingOn March 6, Shanghai Qianqiu Intelligent Technology Co., Ltd., a developer of digital therapeutics for mental rehabilitation, received tens of millions in angel round funding. This round was led by Ruizi Venture Capital, with Zhonglan Innovation serving as the long-term financial advisor. Qianqiu Intelligence provides a full-process digital therapeutic solution based on VR technology for the preliminary diagnosis, rehabilitation training, and post-training evaluation of children with autism. The funds will be used for product development and market expansion.02 Digital Health Industry Dynamics
AbbVie Establishes Strategic Partnership with OSE ImmunotherapeuticsOn February 28, AbbVie and OSE Immunotherapeutics announced a strategic partnership to develop OSE-230, a potential "first-in-class" monoclonal antibody aimed at addressing chronic and severe inflammation. Under the agreement, OSE Immunotherapeutics could receive over $700 million in upfront and milestone payments.Viatris and Idorsia Have Reached a Global R&D Cooperation AgreementOn February 29, Viatris and Idorsia jointly announced that the two companies had reached a global R&D cooperation agreement. According to the agreement, Viatris will obtain the global exclusive development and commercialization rights for Idorsia's two Phase 3 projects, selatogrel and cenerimod, and may acquire other innovative projects from Idorsia in the future. Under the terms of the agreement, Idorsia’s selatogrel and cenerimod development programs and related personnel will be transferred to Viatris, while Idorsia will receive an upfront payment of $350 million, as well as potential development and regulatory milestone payments.Neomorph Collaborates with Novo Nordisk to Develop Molecular Glue DegradersOn February 26, Neomorph announced that it had entered into a collaboration and licensing agreement with Novo Nordisk to jointly discover, develop, and commercialize molecular glue degraders in the fields of cardiometabolic and rare diseases, with a potential total transaction value of up to $1.46 billion.03 Global Digital Health M&A OverviewHaemonetics to Acquire Attune Medical for $160 Million in Upfront CashOn March 5, Haemonetics Corporation, a blood processing technology company, agreed to acquire Attune Medical, the manufacturer of the ensoETM esophageal cooling device, for an initial price of $160 million. The acquisition is expected to immediately boost revenue and earnings growth. The ensoETM technology is used to cool or warm patients under various medical conditions and is the only FDA-approved device for esophageal protection during radiofrequency cardiac ablation.Tiger Jietong Acquires China Branch of International Medical Device CRO GiantOn February 29, Tai Kun Fund, invested by Tai Long Investment, announced that its portfolio company Tiger Jie Tong has acquired NAMSA (Shanghai) Medical Device Science and Technology Consulting Co., LTD, the China branch of the globally renowned medical technology CRO NAMSA. Tiger Jie Tong also signed a strategic cooperation agreement with NAMSA to establish an exclusive partnership in China as well as a global collaboration.ArteryNet/Arterial Orange Industry Think Tank/China Renaissance/BGI Co-Win/Rock Health/Mobile Health News/FierceHealth, etc.
Compiled by: Zhang Qiankun
